Group 1 - The Guangdong Provincial Drug Administration announced that the sodium chloride injection produced by Yangzhou Zhongbao Pharmaceutical Co., Ltd. failed quality inspection due to non-compliance with pH value standards [1][2] - The specific batch number of the non-compliant product is 324102601, and it was tested by the Food and Drug Inspection and Testing Center of Foshan City [2] - The company is required to take risk control measures such as suspending sales, recalling the product, and conducting investigations into the reasons for non-compliance [2] Group 2 - Yangzhou Zhongbao Pharmaceutical Co., Ltd. was established in 1976 and specializes in innovative pharmaceuticals focusing on cardiovascular and chronic respiratory systems [3] - The company is recognized as a national high-tech enterprise and has a comprehensive R&D platform from drug discovery to post-marketing evaluation [3] - It possesses first-class production equipment that meets GMP standards and has established a complete management system for R&D, quality, and production [3]
扬州中宝药业浓氯化钠注射液抽检不合格
Zhong Guo Jing Ji Wang·2025-08-15 07:55